BCL2L11 and lung adenocarcinoma: The aim of this study is to detect the BIM polymorphism in 85 formalinfixed and parrffin-embedded (FFPE) and some blood samples of advanced lung adenocarcinoma patients and study the relativity betweenthe BIM polymorphism and tyrosine kinase inhibitor (TKI).